The first study that has evaluated the prevalence and prognostic significance of PD-L1 in ACC, in a series of 28 patients with ACC, found that 10.7% of the patients were considered PD-L1 positive on tumor cell membrane and 70.4% of tumor-infiltrating lymphocytes, but no relationship to survival was observed [74]. The gene discussed is CD274; the disease is neoplasm.